Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo
- 1 May 2000
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 74 (5), 2213-2216
- https://doi.org/10.1046/j.1471-4159.2000.0742213.x
Abstract
MPTP produces clinical, biochemical, and neuropathologic changes reminiscent of those that occur in idiopathic Parkinson's disease (PD). In the present study we show that MPTP treatment led to activation of microglia in the substantia nigra pars compacta (SNpc), which was associated and colocalized with an increase in inducible nitric oxide synthase (iNOS) expression. In iNOS‐deficient mice the increase of iNOS expression but not the activation of microglia was blocked. Dopaminergic SNpc neurons of iNOS‐deficient mice were almost completely protected from MPTP toxicity in a chronic paradigm of MPTP toxicity. Because the MPTP‐induced decrease in striatal concentrations of dopamine and its metabolites did not differ between iNOS‐deficient mice and their wild‐type littermates, this protection was not associated with a preservation of nigrostriatal terminals. Our results suggest that iNOS‐derived nitric oxide produced in microglia plays an important role in the death of dopaminergic neurons but that other mechanisms contribute to the loss of dopaminergic terminals in MPTP neurotoxicity. We conclude that inhibition of iNOS may be a promising target for the treatment of PD.Keywords
This publication has 21 references indexed in Scilit:
- MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASESAnnual Review of Neuroscience, 1999
- Induction of Nitric Oxide Synthase and Nitric Oxide‐Mediated Apoptosis in Neuronal PC12 Cells After Stimulation with Tumor Necrosis FActor‐α/LipopolysaccharideJournal of Neurochemistry, 1998
- Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's diseaseMovement Disorders, 1998
- Nitric oxide synthase and neuronal vulnerability in parkinson's diseaseNeuroscience, 1996
- Role of nitric oxide in neurodegenerative diseasesCurrent Opinion in Neurology, 1995
- Inhibition of Neuronal Nitric Oxide Synthase by 7‐Nitroindazole Protects Against MPTP‐Induced Neurotoxicity in MiceJournal of Neurochemistry, 1995
- Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related CompoundsJournal of Neurochemistry, 1993
- Characterization of the novel nitric oxide synthase inhibitor 7‐nitro indazole and related indazoles: antinociceptive and cardiovascular effectsBritish Journal of Pharmacology, 1993
- Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphoraseNeuron, 1991
- The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's diseaseJournal of the Neurological Sciences, 1990